基于细胞类型对涎腺意义不明肿瘤进行亚型分型可显示不同的恶性风险
该研究回顾两家机构2006至2017年涎腺细针穿刺病例,按米兰系统重新分类,对92例SUMP病例中有组织学随访的59例进行细胞学亚型分型。
要点
- SUMP病例可进一步分为嗜酸/鳞状、基底样和肌上皮三种细胞亚型。
- 嗜酸/鳞状亚型恶性风险最高(61.1%),肌上皮亚型最低(18.8%)。
核心结论
- 基于细胞类型对SUMP病例进行亚型分型可显示不同的恶性风险,有助于更好的临床分层。
研究设计与样本
- 回顾性检索两家机构2006至2017年涎腺细针穿刺细胞学数据库,按米兰系统重新分类。
- 92例SUMP病例占1560例连续涎腺FNA的5.9%,其中59例有组织学随访。
- 对SUMP病例进行细胞学复核并分为嗜酸/鳞状、基底样和肌上皮亚型,分析各亚型恶性风险。
主要发现
- 59例有随访的SUMP病例中,嗜酸/鳞状亚型18例(30.5%),基底样亚型25例(42.4%),肌上皮亚型16例(27.1%)。
- 嗜酸/鳞状亚型恶性风险为61.1%(11/18),基底样亚型为40.0%(10/25),肌上皮亚型为18.8%(3/16)。
关键数值与推荐
- SUMP占连续涎腺FNA的5.9%(92/1560)。
- 嗜酸/鳞状亚型ROM 61.1%(11/18),基底样亚型ROM 40.0%(10/25),肌上皮亚型ROM 18.8%(3/16)。
临床怎么用
- 对SUMP病例可依据细胞形态进一步亚型分型,以评估不同恶性风险并辅助临床分层管理。
局限性
- 本研究为回顾性设计,且仅59例SUMP病例有组织学随访。
- 未来需前瞻性研究证实该发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The newly unveiled Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) has proposed salivary gland neoplasm of uncertain malignant potential (SUMP) as an indeterminate category. The category is reserved for fine-needle aspiration (FNA) cases that are diagnostic of a salivary gland neoplasm but cannot be further designated as a specific tumor type. The objective of the current study was to evaluate the clinical utility of subtyping SUMP cases based on different cell types. METHODS: A retrospective search of cytology databases at 2 institutions for salivary gland FNAs from 2006 through 2017 was conducted. The cytologic diagnosis of each case was reclassified according to the MSRSGC. Histologic follow-up was retrieved for correlation. Cases reclassified as SUMP that had a follow-up pathologic diagnosis were subject to cytology review and subtyping into oncocytic/squamoid, basaloid, or myoepithelial subtypes based on cytomorphology. The risk of malignancy (ROM) for each subtype was analyzed. RESULTS: There were 92 SUMP cases, which comprised 5.9% of 1560 consecutive salivary gland FNAs within the 12-year study period. Histologic follow-up was available for 59 patients. After cytology review, there were 18 cases (30.5%) of oncocytic/squamoid subtype, 25 (42.4%) of basaloid subtype, and 16 (27.1%) of myoepithelial subtype. Pathologic correlation revealed an ROM of 61.1% (11 of 18 cases) for the oncocytic/squamoid subtype, 40.0% (10 of 25 cases) for the basaloid subtype, and 18.8% (3 of 16 cases) for the myoepithelial subtype. The differences in ROM among the 3 subtypes were statistically significant (P = .0476). CONCLUSIONS: Subtyping SUMP cases into categories based on cell type demonstrated differential ROMs for better clinical stratification. Future prospective studies are mandatory to confirm this finding.
引用
- Hang JF, Alruwaii F, Zeng BR, et al. Subtyping salivary gland neoplasm of uncertain malignant potential based on cell type demonstrates differential risk of malignancy. Cancer Cytopathol. 2018. PMID: 30335220. doi:10.1002/cncy.22066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。